Skip to content
10-Q

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-19-009418

← back to feed
Filed
Jun 19, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Jun 19, 2019 69.62M sh
Cash And Equivalents Q2 2019 · Apr 30, 2019 $11.88K
Cash And Equivalents Q2 2019 · Oct 31, 2018 $6.86K
Current Liabilities Q2 2019 · Apr 30, 2019 $6.48M
Current Liabilities Q2 2019 · Oct 31, 2018 $5.76M
Current Assets Q2 2019 · Apr 30, 2019 $73.45K
Current Assets Q2 2019 · Oct 31, 2018 $39.51K
Total Assets Q2 2019 · Apr 30, 2019 $199.35K
Total Assets Q2 2019 · Oct 31, 2018 $142.4K
Capex Q2 2019 · Apr 30, 2018 $5.26K
Operating Cash Flow Q2 2019 · Apr 30, 2018 −$406.48K
Stockholders Equity Q2 2019 · Apr 30, 2018 −$5.64M
Stockholders Equity Q2 2019 · Oct 31, 2017 −$5M
Sga Expense Q2 2019 · Apr 30, 2018 $118.3K
Sga Expense Q2 2019 · Apr 30, 2018 $239.97K
Rd Expense Q2 2019 · Apr 30, 2018 $7.96K
Rd Expense Q2 2019 · Apr 30, 2018 $23.73K
Net Income Q2 2019 · Apr 30, 2018 −$208.82K
Net Income Q2 2019 · Apr 30, 2018 −$431.36K
Operating Income Q2 2019 · Apr 30, 2018 −$128.59K
Operating Income Q2 2019 · Apr 30, 2018 −$268.21K